000 | 01952 a2200553 4500 | ||
---|---|---|---|
005 | 20250515233151.0 | ||
264 | 0 | _c20110216 | |
008 | 201102s 0 0 eng d | ||
022 | _a1099-0496 | ||
024 | 7 |
_a10.1002/ppul.21302 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFalagas, Matthew E | |
245 | 0 | 0 |
_aInhaled colistin for the treatment of tracheobronchitis and pneumonia in critically ill children without cystic fibrosis. _h[electronic resource] |
260 |
_bPediatric pulmonology _cNov 2010 |
||
300 |
_a1135-40 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Journal Article | ||
650 | 0 | 4 |
_aAcinetobacter Infections _xdrug therapy |
650 | 0 | 4 |
_aAcinetobacter baumannii _xdrug effects |
650 | 0 | 4 | _aAdministration, Inhalation |
650 | 0 | 4 |
_aAlbuterol _xtherapeutic use |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xadministration & dosage |
650 | 0 | 4 |
_aBronchitis _xcomplications |
650 | 0 | 4 |
_aBronchodilator Agents _xtherapeutic use |
650 | 0 | 4 | _aCase-Control Studies |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 |
_aColistin _xadministration & dosage |
650 | 0 | 4 | _aCritical Care |
650 | 0 | 4 | _aCritical Illness |
650 | 0 | 4 |
_aCystic Fibrosis _xcomplications |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHospitals, Pediatric |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aInfant |
650 | 0 | 4 |
_aIpratropium _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aPneumonia, Bacterial _xcomplications |
650 | 0 | 4 |
_aPseudomonas Infections _xdrug therapy |
650 | 0 | 4 |
_aPseudomonas aeruginosa _xdrug effects |
650 | 0 | 4 |
_aTracheitis _xcomplications |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aSideri, Georgia | |
700 | 1 | _aKorbila, Ioanna P | |
700 | 1 | _aVouloumanou, Evridiki K | |
700 | 1 | _aPapadatos, John H | |
700 | 1 | _aKafetzis, Dimitris A | |
773 | 0 |
_tPediatric pulmonology _gvol. 45 _gno. 11 _gp. 1135-40 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/ppul.21302 _zAvailable from publisher's website |
999 |
_c19998731 _d19998731 |